Article
Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Apr 2010
Muller Kate R, Padbury Robert, Jeffrey Gary P, Poplawski Nicola K, Thompson Philip, Tonkin Anne, Harley Hugh A J
Abstract excerpt
Transthyretin amyloid polyneuropathy, caused by mutations in the transthyretin gene, is a progressive condition for which liver transplantation is an established treatment. Favorable outcomes have been described in patients with the most common transthyretin mutation, Val30Met, but outcomes have been variable in patients with other mutations. We describe the cases of 2 siblings with transthyretin amyloid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.